SCHEMBL13664154

SCHEMBL13664154

Cl/N=N\c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1428832 1.00
SCHEMBL1428833 1.00
SCHEMBL16768765 0.94 ALDH1A1 (0.67)
SCHEMBL9848426 0.80 MAPT (0.47)
SCHEMBL9848418 0.80 MAPT (0.47)
SCHEMBL9848405 0.80 MAPT (0.47)
Azobenzene SCHEMBL6703357 0.79 ALDH1A1 (1.00)
Azobenzene SCHEMBL11124477 0.79 ALDH1A1 (1.00)
Azobenzene SCHEMBL11878769 0.79 ALDH1A1 (1.00)
Azobenzene SCHEMBL6562161 0.79 ALDH1A1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed
US-20090170906-A1 HCV INHIBITORS SMITHKLINE BEECHAM CORPORATION 2009-07-02 US disclosed
US-7419997-B2 Tetrahydrocarbazole derivatives and their pharmaceutical use SMITHKLINE BEECHAM CORPORATION (US) 2008-09-02 US disclosed
US-7351733-B2 Tetrahydrocarbazole derivatives and their pharmaceutical use SMITHKLINE BEECHAM CORPORATION (US) 2008-04-01 US disclosed